These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A synthetic route to 3-C-alkyl (or 3-C-phenyl-) 2,3-dideoxy-D-erythro-pentono-1,4-lactones: intermediates in the synthesis of 2(3H)-furanones. Raveendranath PC; Blazis VJ; Agyei-Aye K; Hebbler AK; Gentile LN; Hawkins ES; Johnson SC; Baker DC Carbohydr Res; 1994 Feb; 253():207-23. PubMed ID: 8156548 [TBL] [Abstract][Full Text] [Related]
3. Phospholipids chiral at phosphorus. Synthesis and stereospecificity of phosphorothioate analogues of platelet-activating factor. Rosario-Jansen T; Jiang RT; Tsai MD; Hanahan DJ Biochemistry; 1988 Jun; 27(13):4619-24. PubMed ID: 3167004 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of some benzyl and benzylidene monosubstituted gamma-butyrolactones and tetrahydrofurans as platelet activating factor antagonist agents. Coran SA; Giannellini V; Bambagiotti-Alberti M; Moriggi E; Sala R; Valle G Farmaco; 1995; 50(7-8):511-8. PubMed ID: 7669189 [TBL] [Abstract][Full Text] [Related]
5. Proaggregatory and inhibitory effects of 2-O-ethyl analogues of platelet-activating factor (PAF) on human and rabbit platelets. Hofmann B; Ostermann G; Kertscher HP; Till U Thromb Res; 1988 Feb; 49(4):415-23. PubMed ID: 3381200 [TBL] [Abstract][Full Text] [Related]
6. Analogues of platelet activating factor. 5. Multiple oxygen substitution of the alkoxy chain. Wissner A; Kohler CA; Goldstein BM J Med Chem; 1986 Jul; 29(7):1315-9. PubMed ID: 3806583 [TBL] [Abstract][Full Text] [Related]
7. Release of 1-O-alkylglyceryl 3-phosphorylcholine, O-deacetyl platelet-activating factor, from leukocytes: chemical ionization mass spectrometry of phospholipids. Polonsky J; Tencé M; Varenne P; Das BC; Lunel J; Benveniste J Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7019-23. PubMed ID: 6938950 [TBL] [Abstract][Full Text] [Related]
10. [PAF-antagonists with phospholipid structure. 2. Phospholipids with heteroarene head groups and variations of the phosphorus-nitrogen distance; synthesis, characterization and structure-activity relationships]. Kertscher HP; Ostermann G Pharmazie; 1991 Oct; 46(10):708-11. PubMed ID: 1803385 [TBL] [Abstract][Full Text] [Related]
11. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. I. Studies on blood platelets in vitro. Ostermann G; Hofmann B; Kertscher HP; Till U J Lipid Mediat; 1990; 2(1):21-31. PubMed ID: 1966804 [TBL] [Abstract][Full Text] [Related]
12. The mutarotation of 2-deoxy- -D-erythro-pentose ("2-deoxy- -D-ribose"). Conformations, kinetics, and equilibria. Lemieux RU; Anderson L; Conner AH Carbohydr Res; 1971 Nov; 20(1):59-72. PubMed ID: 5151198 [No Abstract] [Full Text] [Related]
13. Synthesis and antiplatelet evaluation of alpha-methylene-gamma-butyrolactone bearing 2-methylquinoline and 8-hydroxyquinoline moieties. Liou SS; Zhao YL; Chang YL; Teng CM; Tzeng CC Chem Pharm Bull (Tokyo); 1997 Nov; 45(11):1777-81. PubMed ID: 9396153 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of PAF-induced human platelet responses by newly synthesized ether phospholipids. Ostermann G; Hofmann B; Kertscher HP; Till U Thromb Res; 1991 Feb; 61(3):261-9. PubMed ID: 2028445 [TBL] [Abstract][Full Text] [Related]
15. Platelet aggregation induced by ether-linked phospholipids. 2. Mechanism of desensitization of rabbit platelets by platelet activating factor and reversibility of inhibitory actions of its antagonists. Tokumura A; Yoshida J; Okasaka N; Fukuzawa K; Tsukatani H Thromb Res; 1987 Apr; 46(1):153-61. PubMed ID: 3590110 [TBL] [Abstract][Full Text] [Related]
16. Analogues of platelet activating factor. 6. Mono- and bis-aryl phosphate antagonists of platelet activating factor. Wissner A; Carroll ML; Green KE; Kerwar SS; Pickett WC; Schaub RE; Torley LW; Wrenn S; Kohler CA J Med Chem; 1992 May; 35(9):1650-62. PubMed ID: 1578493 [TBL] [Abstract][Full Text] [Related]
17. Analogues of platelet activating factor (PAF). 2. Some modifications of the glycerine backbone. Wissner A; Schaub RE; Sum PE; Kohler CA; Goldstein BM J Med Chem; 1985 Sep; 28(9):1181-7. PubMed ID: 4032422 [TBL] [Abstract][Full Text] [Related]
18. Platelet-stimulating and membranolytic properties of racemic PAF-acether and analogues. Ostermann G; Kertscher HP; Till U Biomed Biochim Acta; 1985; 44(2):K17-23. PubMed ID: 4004829 [TBL] [Abstract][Full Text] [Related]
19. Development of a new reaction system for the synthesis of highly optically active alpha,gamma-substituted gamma-butyrolactones. Xu MH; Wang W; Xia LJ; Lin GQ J Org Chem; 2001 Jun; 66(11):3953-62. PubMed ID: 11375020 [TBL] [Abstract][Full Text] [Related]
20. Effect of structural analogues of PAF-acether on platelet desensitization. Keraly CL; Coëffier E; Tencé M; Borrel MC; Benveniste J Br J Haematol; 1983 Mar; 53(3):513-21. PubMed ID: 6824590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]